MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR

PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment

(2016) Angel Guerrero-Zotano et al.   CANCER AND METASTASIS REVIEWS

Unfolded Protein Response Promotes Doxorubicin-Induced Nonsmall Cell Lung Cancer Cells Apoptosis via the mTOR Pathway Inhibition

(2016) Xiaofang Zhao et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α

(2016) Shuo Chen et al.   Molecular Cancer

Inhibition of Rb Phosphorylation Leads to mTORC2-Mediated Activation of Akt

(2016) Jinfang Zhang et al.   MOLECULAR CELL

mTOR inhibitors in urinary bladder cancer

(2016) R. Pinto-Leite et al.   TUMOR BIOLOGY

Valproic acid induces autophagy by suppressing the Akt/mTOR pathway in human prostate cancer cells

(2016) Qinghua Xia et al.   Oncology Letters

MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies

(2015) G S Choudhary et al.   Cell Death & Disease

FLT3-ITD confers resistance to the PI3K/Akt pathway inhibitors by protecting the mTOR/4EBP1/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia

(2015) Ayako Nogami et al.   Oncotarget

MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells

(2015) Yosuke Konno et al.   Oncotarget

mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: A critical review

(2014) Nader Husseinzadeh et al.   GYNECOLOGIC ONCOLOGY

Combined MicroRNA-340 and ROCK1 mRNA Profiling Predicts Tumor Progression and Prognosis in Pediatric Osteosarcoma

(2014) Haiqing Cai et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway

(2014) Takashi Mitamura et al.   Molecular Cancer

Molecular Alterations of PI3K/Akt/mTOR Pathway: A Therapeutic Target in Endometrial Cancer

(2014) Athanasia Pavlidou et al.   TheScientificWorldJOURNAL

MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2

(2013) Chonglin Luo et al.   CANCER LETTERS

Dual mTORC1/2 inhibition in a preclinical xenograft tumor model of endometrial cancer

(2013) Sharmilee Bansal Korets et al.   GYNECOLOGIC ONCOLOGY

miRNA-101: A potential target for tumor therapy

(2012) Ting Gui et al.   Cancer Epidemiology

Genotype-Dependent Efficacy of a Dual PI3K/mTOR Inhibitor, NVP-BEZ235, and an mTOR Inhibitor, RAD001, in Endometrial Carcinomas

(2012) Keiko Shoji et al.   PLoS One

MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma

(2011) Eri Hiroki et al.   INTERNATIONAL JOURNAL OF CANCER

MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion

(2010) Hui-Ju Wang et al.   EUROPEAN JOURNAL OF CANCER

Synergistic effect of rapamycin and cisplatin in endometrial cancer cells

(2009) Victoria L. Bae-Jump et al.   CANCER

Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas

(2009) Eri Hiroki et al.   CANCER SCIENCE

MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells

(2008) Antonio Strillacci et al.   EXPERIMENTAL CELL RESEARCH

Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro

(2008) Silvia Darb-Esfahani et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY